Literature DB >> 7775200

Immunohistochemical detection of oncoprotein 18 (Op18) in malignant lymphomas.

K Nylander1, U Marklund, G Brattsand, M Gullberg, G Roos.   

Abstract

Expression of oncoprotein 18 (Op18), an intracellular phosphoprotein up-regulated in many malignant cell types, was evaluated in a series of normal lymphoid tissue and malignant lymphomas. In normal tonsils and reactive lymph nodes, the majority of Op18-positive cells were present in the germinal centres, whereas cells in the mantle zone were essentially negative and the interfollicular areas showed occasional positive cells. Double staining for PCNA and Op18 revealed that Op18 expression only to some extent was correlated with cell proliferation, as determined by PCNA expression. Non-Hodgkin's lymphomas exhibited a variable Op18 expression, and in Hodgkin's disease, Reed-Sternberg and Hodgkin cells frequently expressed Op18 with a strong staining intensity. Using Op18-PCNA double staining in malignant lymphomas, Op18 expression could also be partially dissociated from cell proliferation. By using confocal microscopy, the intracellular localization of Op18 was studied, demonstrating diffuse reactivity in the cytoplasm in interphase cells and during mitosis, whereas nuclei and condensed chromosomes were negative. In conclusion, Op18 was expressed at variable levels in most, perhaps all, proliferating lymphocytes in benign lymphoid tissue as well as in malignant lymphomas. However, the Op18 protein was also detected in a significant fraction of apparently non-cycling normal and neoplastic lymphocytes.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7775200     DOI: 10.1007/bf00243911

Source DB:  PubMed          Journal:  Histochem J        ISSN: 0018-2214


  19 in total

1.  N-myc gene amplification in neuroblastoma is associated with altered phosphorylation of a proliferation related polypeptide (Op18).

Authors:  N Hailat; J Strahler; R Melhem; X X Zhu; G Brodeur; R C Seeger; C P Reynolds; S Hanash
Journal:  Oncogene       Date:  1990-11       Impact factor: 9.867

2.  The complexities of proliferating cell nuclear antigen.

Authors:  D McCormick; P A Hall
Journal:  Histopathology       Date:  1992-12       Impact factor: 5.087

3.  Activation-dependent phosphorylation of endogenous protein kinase C substrates in quiescent human T lymphocytes.

Authors:  B Friedrich; K Noreus; D A Cantrell; M Gullberg
Journal:  Immunobiology       Date:  1988-03       Impact factor: 3.144

4.  High expression of stathmin in multipotential teratocarcinoma and normal embryonic cells versus their early differentiated derivatives.

Authors:  V Doye; O Kellermann; M H Buc-Caron; A Sobel
Journal:  Differentiation       Date:  1992-06       Impact factor: 3.880

5.  Cell-cycle-regulated phosphorylation of oncoprotein 18 on Ser16, Ser25 and Ser38.

Authors:  G Brattsand; U Marklund; K Nylander; G Roos; M Gullberg
Journal:  Eur J Biochem       Date:  1994-03-01

6.  Characterization of the gene for a proliferation-related phosphoprotein (oncoprotein 18) expressed in high amounts in acute leukemia.

Authors:  R F Melhem; X X Zhu; N Hailat; J R Strahler; S M Hanash
Journal:  J Biol Chem       Date:  1991-09-25       Impact factor: 5.157

7.  Molecular cloning of a novel human leukemia-associated gene. Evidence of conservation in animal species.

Authors:  X X Zhu; K Kozarsky; J R Strahler; C Eckerskorn; F Lottspeich; R Melhem; J Lowe; D A Fox; S M Hanash; G F Atweh
Journal:  J Biol Chem       Date:  1989-08-25       Impact factor: 5.157

8.  Human peripheral lymphocyte growth regulation and response to phorbol esters is linked to synthesis and phosphorylation of the cytosolic protein, prosolin.

Authors:  H L Cooper; E McDuffie; R Braverman
Journal:  J Immunol       Date:  1989-08-01       Impact factor: 5.422

9.  A single cDNA encodes two isoforms of stathmin, a developmentally regulated neuron-enriched phosphoprotein.

Authors:  V Doye; F Soubrier; G Bauw; M C Boutterin; L Beretta; J Koppel; J Vandekerckhove; A Sobel
Journal:  J Biol Chem       Date:  1989-07-25       Impact factor: 5.157

10.  Multiple signal transduction pathways induce phosphorylation of serines 16, 25, and 38 of oncoprotein 18 in T lymphocytes.

Authors:  U Marklund; G Brattsand; O Osterman; P I Ohlsson; M Gullberg
Journal:  J Biol Chem       Date:  1993-12-05       Impact factor: 5.157

View more
  13 in total

1.  The microtubule cytoskeleton is required for a G2 cell cycle delay in cancer cells lacking stathmin and p53.

Authors:  Bruce K Carney; Victoria Caruso Silva; Lynne Cassimeris
Journal:  Cytoskeleton (Hoboken)       Date:  2012-03-29

Review 2.  Mechanisms of Taxol resistance related to microtubules.

Authors:  George A Orr; Pascal Verdier-Pinard; Hayley McDaid; Susan Band Horwitz
Journal:  Oncogene       Date:  2003-10-20       Impact factor: 9.867

3.  Analysis of gene expression identifies candidate molecular markers in nasopharyngeal carcinoma using microdissection and cDNA microarray.

Authors:  Zhaoyang Zeng; Yanhong Zhou; Wei Xiong; Xiaomin Luo; Wenling Zhang; Xiaoling Li; Songqing Fan; Li Cao; Ke Tang; Minghua Wu; Guiyuan Li
Journal:  J Cancer Res Clin Oncol       Date:  2006-06-21       Impact factor: 4.553

4.  Anti-centrosome antibodies in breast cancer are the expression of autoimmunity.

Authors:  Marie-Claire Maroun; Ofelia Olivero; Leonard Lipovich; Azadeh Stark; Larry Tait; Sudeshna Bandyopadhyay; Matthew Burke; Richard Zarbo; Dhananjay Chitale; S David Nathanson; Mike Long; Carol Peebles; Félix Fernández Madrid
Journal:  Immunol Res       Date:  2014-12       Impact factor: 2.829

5.  Differential proteomic analysis of a highly metastatic variant of human breast cancer cells using two-dimensional differential gel electrophoresis.

Authors:  Si-Guang Xu; Pei-Jun Yan; Zhi-Ming Shao
Journal:  J Cancer Res Clin Oncol       Date:  2010-02-14       Impact factor: 4.553

6.  Stathmin-deficient mice develop an age-dependent axonopathy of the central and peripheral nervous systems.

Authors:  Wolfgang Liedtke; Elizabeth E Leman; Robert E W Fyffe; Cedric S Raine; Ulrich K Schubart
Journal:  Am J Pathol       Date:  2002-02       Impact factor: 4.307

7.  Overexpression of stathmin in breast carcinomas points out to highly proliferative tumours.

Authors:  P A Curmi; C Noguès; S Lachkar; N Carelle; M P Gonthier; A Sobel; R Lidereau; I Bièche
Journal:  Br J Cancer       Date:  2000-01       Impact factor: 7.640

8.  Correlation of oncoprotein 18/stathmin expression in human breast cancer with established prognostic factors.

Authors:  G Brattsand
Journal:  Br J Cancer       Date:  2000-08       Impact factor: 7.640

9.  Overexpression of the stathmin gene in a subset of human breast cancer.

Authors:  I Bièche; S Lachkar; V Becette; C Cifuentes-Diaz; A Sobel; R Lidereau; P A Curmi
Journal:  Br J Cancer       Date:  1998-09       Impact factor: 7.640

Review 10.  Stathmin 1 in normal and malignant hematopoiesis.

Authors:  João Agostinho Machado-Neto; Sara Teresinha Olalla Saad; Fabiola Traina
Journal:  BMB Rep       Date:  2014-12       Impact factor: 4.778

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.